4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-035340
Director sold 29,101 shares at an average $353.19 ($10,278,098)
- Director acquired 29,101 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2025-07-16 | Option exercise 10b5-1 | +26,444 | $9.45 | $249,896 | 487,488 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −6,000 | $350.19 | $2,101,142 | 481,488 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −1,897 | $351.37 | $666,546 | 479,591 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −2,357 | $352.64 | $831,170 | 477,234 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −2,569 | $353.82 | $908,963 | 474,665 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −5,800 | $354.61 | $2,056,738 | 468,865 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −6,441 | $355.61 | $2,290,499 | 462,424 | D |
| Taub Rebecca Director | 2025-07-16 | Sale 10b5-1 | −1,380 | $356.52 | $492,004 | 461,044 | D |
| Taub Rebecca Director | 2025-07-17 | Option exercise 10b5-1 | +2,657 | $9.45 | $25,109 | 463,701 | D |
| Taub Rebecca Director | 2025-07-17 | Sale 10b5-1 | −2,057 | $350.09 | $720,137 | 461,644 | D |
| Taub Rebecca Director | 2025-07-17 | Sale 10b5-1 | −600 | $351.50 | $210,898 | 461,044 | D |
| Derivatives | |||||||
| Taub Rebecca Director | 2025-07-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −26,444 | 50,120 | D | ||
| Taub Rebecca Director | 2025-07-17 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,657 | 47,463 | D | ||
| Open-market sales · 29,101 sh · avg $353.19 · $10,278,098 | |||||||
Loading xslF345X05/wk-form4_1752869497.xml…